SEC Form 4 · accession 0001493152-26-032233
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew J. Last
Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 8:38 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1 | Jul 1, 2026 | F | 7,700 | $5.69 | D | 58,752 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.